Abstract

Ocular tumors are rare enough that many general ophthalmologists will see only one to a handful during a career. Ocular tumors encompass a wide spectrum of disorders and can be divided into intraocular, conjunctival, eyelid and orbital tumors. The basis of ocular tumor management historically has been biased towards excisional therapy or enucleation, resulting in significant morbidity and loss of vision. More recently treatments have emerged which salvage the globe, do not decrease the survival rate. As we continue to learn more about the etiology, genetics, the molecular pathways of these tumors, there is hope that new therapeutic approaches will evolve. We review the pathology, epidemiology, clinical features, treatment options and future management directions of the most common intraocular tumors.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call